-
Je něco špatně v tomto záznamu ?
Dendritic cell counts and their subsets during treatment of multiple myeloma
L Kovarova, T Buchler, L Pour, L Zahradova, D Ocadlikova, A Svobodnik, M Penka, J Vorlicek, R Hajek
Jazyk angličtina Země Slovensko
Grantová podpora
NR8081
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
- MeSH
- antigeny CD11c metabolismus MeSH
- autologní transplantace MeSH
- časové faktory MeSH
- CD antigeny metabolismus MeSH
- dendritické buňky cytologie klasifikace MeSH
- dexamethason aplikace a dávkování MeSH
- doxorubicin aplikace a dávkování MeSH
- faktor stimulující kolonie granulocytů aplikace a dávkování MeSH
- financování organizované MeSH
- HLA-DR antigeny metabolismus MeSH
- imunoglobuliny metabolismus MeSH
- indukce remise MeSH
- kombinovaná terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- membránové glykoproteiny metabolismus MeSH
- mnohočetný myelom imunologie metabolismus terapie MeSH
- počet buněk MeSH
- protokoly protinádorové kombinované chemoterapie terapeutické užití MeSH
- průtoková cytometrie MeSH
- receptor interleukinu-3 - alfa-podjednotka metabolismus MeSH
- transplantace periferních kmenových buněk MeSH
- vinkristin aplikace a dávkování MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
Human dendritic cells have distinct roles in the regulation of immunity. In this study we analysed the kinetics and the proportion of myeloid and plasmacytoid subsets of dendritic cells (DC) in peripheral blood of 15 patients with multiple myeloma (MM) before and during treatment that included autologous transplantation. Control group of 15 healthy volunteers was evaluated by using the same approaches. Flowcytometric determination of relative and absolute cell counts in unmanipulated peripheral blood was based on the expression of surface antigens CD83 and HLA-DR. Depending on the expression of CD11c or CD123, we divided these cells into CD11c+ dendritic cells type 1 (DC1) and CD123+ DC type 2 (DC2). Significant differences were found in initial relative counts of CD83+ cells and of the DC2 subtype between the group of controls and the group of patients before treatment. In absolute counts, there was a difference only in the DC2 subtype. After induction treatment (vincristine, doxorubicin, and dexamethasone), the mean percentage of CD83+ DC and the DC1 percentage were significantly higher than initially, but there was no significant difference in absolute counts. Administration of G-CSF again increased the total DC numbers. Intermediate DC counts were found in the apheresis products. After engraftment, we found the highest relative DC numbers, but absolute counts were not very high because of leukopenia. Within six months after transplantation, normal relative and absolute DC counts were found in patients. Untreated patients with MM have significantly lower relative numbers of peripheral blood DC in comparison with healthy volunteers. The highest number of total DC was found after engraftment. The DC1/DC2 ratio showed relative predominance of DC1 subtype and the lowest DC1/DC2 ratio was found in the apheresis products. DC counts comparable with those of healthy volunteers were found in patients six months after transplantation.
- 000
- 04381naa 2200625 a 4500
- 001
- bmc10015038
- 003
- CZ-PrNML
- 005
- 20130923162846.0
- 008
- 100623s2007 xo e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Říhová, Lucie $7 xx0081970
- 245 10
- $a Dendritic cell counts and their subsets during treatment of multiple myeloma / $c L Kovarova, T Buchler, L Pour, L Zahradova, D Ocadlikova, A Svobodnik, M Penka, J Vorlicek, R Hajek
- 314 __
- $a Laboratory of Experimental Hematology and Immunotherapy, Department of Clinical Hematology, University Hospital, Czech Republic lkovarova@fnbrno.cz
- 520 9_
- $a Human dendritic cells have distinct roles in the regulation of immunity. In this study we analysed the kinetics and the proportion of myeloid and plasmacytoid subsets of dendritic cells (DC) in peripheral blood of 15 patients with multiple myeloma (MM) before and during treatment that included autologous transplantation. Control group of 15 healthy volunteers was evaluated by using the same approaches. Flowcytometric determination of relative and absolute cell counts in unmanipulated peripheral blood was based on the expression of surface antigens CD83 and HLA-DR. Depending on the expression of CD11c or CD123, we divided these cells into CD11c+ dendritic cells type 1 (DC1) and CD123+ DC type 2 (DC2). Significant differences were found in initial relative counts of CD83+ cells and of the DC2 subtype between the group of controls and the group of patients before treatment. In absolute counts, there was a difference only in the DC2 subtype. After induction treatment (vincristine, doxorubicin, and dexamethasone), the mean percentage of CD83+ DC and the DC1 percentage were significantly higher than initially, but there was no significant difference in absolute counts. Administration of G-CSF again increased the total DC numbers. Intermediate DC counts were found in the apheresis products. After engraftment, we found the highest relative DC numbers, but absolute counts were not very high because of leukopenia. Within six months after transplantation, normal relative and absolute DC counts were found in patients. Untreated patients with MM have significantly lower relative numbers of peripheral blood DC in comparison with healthy volunteers. The highest number of total DC was found after engraftment. The DC1/DC2 ratio showed relative predominance of DC1 subtype and the lowest DC1/DC2 ratio was found in the apheresis products. DC counts comparable with those of healthy volunteers were found in patients six months after transplantation.
- 650 _2
- $a CD antigeny $x metabolismus $7 D015703
- 650 _2
- $a antigeny CD11c $x metabolismus $7 D039521
- 650 _2
- $a protokoly protinádorové kombinované chemoterapie $x terapeutické užití $7 D000971
- 650 _2
- $a počet buněk $7 D002452
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a dendritické buňky $x cytologie $x klasifikace $7 D003713
- 650 _2
- $a dexamethason $x aplikace a dávkování $7 D003907
- 650 _2
- $a doxorubicin $x aplikace a dávkování $7 D004317
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a faktor stimulující kolonie granulocytů $x aplikace a dávkování $7 D016179
- 650 _2
- $a HLA-DR antigeny $x metabolismus $7 D006684
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobuliny $x metabolismus $7 D007136
- 650 _2
- $a receptor interleukinu-3 - alfa-podjednotka $x metabolismus $7 D053650
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové glykoproteiny $x metabolismus $7 D008562
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mnohočetný myelom $x imunologie $x metabolismus $x terapie $7 D009101
- 650 _2
- $a transplantace periferních kmenových buněk $7 D036102
- 650 _2
- $a indukce remise $7 D012074
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a autologní transplantace $7 D014182
- 650 _2
- $a vinkristin $x aplikace a dávkování $7 D014750
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Büchler, Tomáš, $7 xx0096851 $d 1974-
- 700 1_
- $a Pour, Luděk $7 xx0102556
- 700 1_
- $a Szeligová, Lenka $7 xx0098951
- 700 1_
- $a Očadlíková, Darina. $7 xx0181164
- 700 1_
- $a Svobodník, Adam, $d 1975- $7 xx0026812
- 700 1_
- $a Penka, Miroslav, $d 1952- $7 nlk19990073680
- 700 1_
- $a Vorlíček, Jiří, $d 1944- $7 jn20000402598
- 700 1_
- $a Hájek, Roman, $d 1964- $7 nlk20000083645
- 773 0_
- $t Neoplasma $w MED00003470 $g Roč. 54, č. 4 (2007), s. 297-303 $x 0028-2685
- 910 __
- $a ABA008 $b A 1194 $y 8
- 990 __
- $a 20100630115239 $b ABA008
- 991 __
- $a 20130923163356 $b ABA008
- 999 __
- $a ok $b bmc $g 750906 $s 614584
- BAS __
- $a 3
- BMC __
- $a 2007 $b 54 $c 4 $d 297-303 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- GRA __
- $a NR8081 $p MZ0
- LZP __
- $a 2010-B1/mkme